About this trial
This study will evaluate whether a digital-supported informed consent process improves patient understanding before advanced therapeutic endoscopy procedures.
Patients undergoing advanced therapeutic endoscopy are often asked to make decisions about procedures that may be complex and involve important risks, benefits, and alternatives. Standard informed consent is usually provided through discussion with the treating physician. However, this process can vary between clinicians and may be affected by time pressures in busy endoscopy units.
In this study, eligible adult patients scheduled for elective advanced therapeutic endoscopy will be randomly assigned to one of two consent pathways. One group will receive standard physician-led informed consent. The other group will receive a digital-supported consent pathway that includes a standardized procedure-specific educational video, an offline artificial intelligence-based question-answering tool, and final confirmation with the treating physician before the procedure.
The digital tool is designed to provide plain-language information about the procedure, including why it is being done, expected benefits, common and serious risks, alternatives, what to expect before and after the procedure, and the patient's right to ask questions or decline the procedure. The AI question-answering tool will use only investigator-approved educational content and will not provide individualized medical advice. Questions requiring patient-specific medical judgment will be directed back to the treating clinical team.
The main outcome of the study is patient comprehension of the consent information, measured after the assigned consent process and before the procedure. The study will also evaluate patient anxiety, satisfaction, confidence in decision-making, usability of the consent process, workflow outcomes, and consent-related safety or ethical concerns.
Eligibility criteria
Qualifiers
Adults aged 18 years or older
Scheduled to undergo elective advanced therapeutic endoscopy
Able to provide informed consent for study participation
Able to engage with study materials in a language supported by the site
Disqualifiers
Emergent or urgent procedures where the consent process cannot reasonably incorporate the study intervention
Inability or unwillingness to provide informed consent for study participation
Requirement for substitute decision-maker consent for the procedural decision itself, if this precludes meaningful use of the study intervention
Severe cognitive, visual, hearing, or communication limitations not adequately accommodated by site resources
Trial design
Treatments tested in this trial
- Digital-Supported Informed Consent Pathway
- Standard Physician-Led Informed Consent
Treatment groups
Sponsors and collaborators
Unity Health Toronto
Lead sponsor
University of Toronto
Collaborator